Table 1 Patient population demographics and their maintenance treatment regimens at time of exacerbation
Population Demographic | Number of patients (%) (n = 70) |
|---|---|
Sex (Male) | 47% |
Race – White | 96% |
Race—Black | 4% |
Seropositive Statusb | 63% |
Thymectomy | 21% |
Maintenance Treatment | Number (%) of maintenance regimens at time of exacerbation (n = 141) |
Steroid Sparing Agentsa | 26.2% |
Maintenance IVIG | 21.3% |
Maintenance Plasmapheresis | 7.1% |
Prednisone | 37.6% |
Pyridostigmine | 77.3% |
Monoclonal Antibodies† | 1.4% |
> 1 Treatment | 66% |
None | 16.3% |